Is Theravance Biopharma, Inc. technically bullish or bearish?

Sep 20 2025 07:54 PM IST
share
Share Via
As of June 2, 2025, Theravance Biopharma, Inc. shows a bullish trend supported by positive MACD, Bollinger Bands, and moving averages, despite bearish RSI readings and mixed Dow Theory signals, while outperforming the S&P 500 with a year-to-date return of 53.77%.
As of 2 June 2025, the technical trend for Theravance Biopharma, Inc. has changed from mildly bullish to bullish. The current stance is bullish, with key indicators supporting this view including bullish MACD readings on both weekly and monthly timeframes, bullish Bollinger Bands, and bullish moving averages on the daily timeframe. However, the RSI is bearish on both weekly and monthly timeframes, and Dow Theory indicates a mildly bearish stance on the weekly timeframe while being mildly bullish monthly.

In terms of performance, the stock has outperformed the S&P 500 across multiple periods, with a year-to-date return of 53.77% compared to the S&P 500's 12.22%, and a one-year return of 74.97% versus 17.14%.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News